Grand Rounds

Program Coordinator: Micaela Jones (Sandoval) 503-494-4818


Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians


OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience

Psychiatrists, psychologists, psychiatry residents and fellows, medical students, social workers, masters in administration, physician assistants, nurse practitioners, nurses and pharmacists. Additionally, Psychiatry Grand Rounds is open to the public.

smll stnly

 Program Co-Chair:

Assistant Professor of Psychiatry, OHSU

 Assistant Program Director, Adult Psychiatry Residency Training, OHSU

small stephanie lopez headshot

Program Co-Chair:

Associate Professor of Psychiatry, OHSU

Associate Program Director, Forensic Psychiatry Fellowship Program, OHSU

Board-certified in General and Forensic Psychiatry

8B60 Auditorium

Typically held the 1st, 3rd & 4th Tuesdays of each month

Noon to 1pm, 8B60, 8th Floor, OHSU Hospital (unless otherwise noted)

Psychiatry Grand Rounds provides continuing medical education for the public. We strive to enable discussion that is both about and involves the patient so the physician can better understand the depth of one's mental illness. In Psychiatry Grand Rounds, we explore the history of certain policies and procedures in place for handling mentally ill patients and what can happen to improve care and treatment that they receive, as well as to better explain and expand on various forms of mental illness and how treatment should be approached and practiced by the clinician.

Accessing Psychiatry Grand Rounds Remotely

Our lectures are accessible to be viewed remotely, simply connect using this link: 

To receive CME credit, you must watch the lecture live during the time of the presentation. After you watch the Grand Rounds, you can submit your attendance by filling out an evaluation survey, the link to which is given in the announcement emails. You can sign up for the announcements by scrolling to the bottom of this page and filling out your information. If you have any questions please contact the Grand Rounds Coordinator, Micaela Sandoval at or 503-494-4818.

Psychiatry Grand Rounds Schedule

Sept. 11, 2018

Mental Health Across the Medical Education Continuum: The Imperative for Change

Stuart Slavin, M.D., M.Ed. - Senior Scholar for Well-Being, ACGME

  • List the mental health outcomes seen in medical students, residents, and physicians.
  • Describe the model, interventions, and outcomes from the mental health inititative for medical students and pediatric residents at Saint Louis University.
  • Describe the sources of burnout in the clinical environment and how they canbe influenced.
  • Describe individual tools that can be used to promote resilience and well-being.


Sept. 18, 2018

Epigenomic Trajectories to Neuropsychiatric and Neurodegenerative Disease

Jonathan Mill, Ph.D. - Professor of Epigenetics, University of Exeter Medical School, United Kingdom.

  • Identify epigenetic variation associated with a diverse range of neuropsychiatric phenotypes.
  • Describe an analysis of dynamic DNA modifications across human brain development.
  • Describe the impact of genetic variation on the epigenome during brain development.
  • Discuss the feasibility of identifying peripheral biomarkers of disease phenotypes manifest I inaccessible tissues such at the brain.


Sept. 25, 2018

Can ADHD Treatment Be Improved?

James McCracken, M.D. - Director of Child and Adolescent Psychiaty Developmental Disabilities Clinic, Professor of Psychiatry and Biobehavioral Sciences, Brain Research Institute, UCLA

  • Discuss the scope, impact, and natural history of ADHD
  • Analyze the current approach to the treatment of ADHD and list the unmet needs of this standard of care
  • List the challenges and opportunities for improving treatment for ADHD


Oct. 2, 2018

Early Life Predictors of Risk for Psychopathology

Hanna Gustafsson, Ph.D. - Postdoctoral Fellow, Clinical Psychology, OHSU

  • Describe early environment influences on child risk for psychopathology
  • Identify aspects of infant and child behavior that may convey such risk
  • Understand mechanisms through which prenatal and early life experience influence mental health


Oct. 16, 2018


Oct. 23, 2018

Topic Title TBD

Travis Lovejoy, Ph.D., M.P.H - Clinical and Health Services Researches, VA Portland Healthcare System, Assistant Professor of Psychiatry and School of Public Health, OHSU


Nov. 6, 2018

Evidence Based Approach to Low Libido in Women

Nicole Cirino, M.D. - Director of the Division of Women's Mental Health and Wellness, Professor of Obstetrics and Gynecology, OHSU

  • Identify Neurobiological etiology of libido in women, particularly in the female psychiatric patient.
  • List at least 3 behavioral approaches that can improve libido in women.
  • List at least 3 psychopharmacologic treatments that can address low libido in the female psychiatric patient.

 Nov. 27, 2018 

Ketamine Treatment for an Adolescent with Psychotic Depression

Keith Cheng, M.D. - Clinical Associate Professor of Psychiatry, OHSU. Interim Medical Director, Adolescent Program at Unity Center for Behavioral Health

Jay Kothari, M.D. - Assistant Professor of Psychiatry, OHSU. Psychistrist, Unity Center for Behavioral Health

Paria Zarrinnegar, M.D. - Adjunct Assistant Professor, OHSU. Psychiatrist, Unity Center for Behavioral Health

  • List the indications for using Ketamine to treat mood disorders in adolescents.
  • Discuss the present protocols for administering Ketamine infusions.
  • Analyze the present theories of the mechanism of action of Ketamine.
  • Discuss the present barriers for using Ketamine in adolescents.


Dec. 4, 2018

Interventional Psychiatry: ECT, TMS, and Ketamine

Anne Fang, M.D. - Director of ECT Services, Assistant Professor of Psychiatry, OHSU

  • Identify indications for ECT, TMS, and Ketamine.
  • Describe contraindications and common adverse effects of each treatment option.
  • Compare and contrast the risks versus benefits of each treatment option.
  • Discuss medication modification in anticipation of ECT treatments.
  • Describe what patients should expect during each type of treatment.


Dec. 18, 2018

Grand Rounds Notification

We send out notifications a few days in advance of Grand Rounds. If you would like to receive these notifications, please fill out the form below.

Full name: